IDSA GUIDELINES Bundle (free trial)

Drug-Susceptible Tuberculosis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/770889

Contents of this Issue

Navigation

Page 20 of 23

21 Table 8. Clinically Significant Drug–Drug Interactions Involving the Rifamycins a (cont'd) Table 9. Suggested Pyrazinamide Doses, Using Whole Tablets, for Adults Weighing 40–90 kg a Regimen Weight, kg b,c 40–55 56–75 76–90 Daily (mg/kg ) 1000 mg (18.2–25.0) 1500 mg (20.0–26.8) 2000 mg (22.2–26.3) rice weekly (mg/kg ) 1500 mg (27.3–37.5) 2500 mg (33.3–44.6) 3000 mg (33.3–39.5) Twice weekly (mg/kg ) 2000 mg (36.4–50.0) 3000 mg (40.0–53.6) 4000 mg (44.4–52.6) a With normal renal function. b Based on estimated lean body weight. Optimal doses for obese patients are not established. c Numbers in parentheses are the calculated mg/kg doses for patients at the highest and lowest body weights in the weight band. Psychotropic drugs Nortriptyline TDM recommended; may require dose increase or change to alternate psychotropic drug. Haloperidol, quetiapine Monitor clinically; may require a dose increase or use of an alternate psychotropic drug. Benzodiazepines (eg, diazepam, triazolam), zolpidem, buspirone) Monitor clinically; may require a dose increase or use of an alternate psychotropic drug. a See the following useful websites for updated information regarding drug interactions: AIDSinfo [http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf ], Centers for Disease Control and Prevention [http://www.cdc.gov/tb/publications/guidelines/ TB_HIV_Drugs/default.htm], University of California San Francisco [http://hivinsite.ucsf.edu/insite?page=ar-00-02], University of Liverpool [http://www.hiv-druginteractions.org/], Indiana University [http://medicine.iupui.edu/clinpharm/ddis/], and University of Maryland [http://umm.edu/health/medical/drug-interaction-tool].

Articles in this issue

Links on this page

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Drug-Susceptible Tuberculosis